|
Volumn 379, Issue 4, 2009, Pages 413-415
|
Should we be cautious on the use of commercially available antibodies to dopamine receptors?
|
Author keywords
Dopamine receptors; Selectivity; Western blot
|
Indexed keywords
DOPAMINE 1 RECEPTOR;
DOPAMINE 1 RECEPTOR ANTIBODY;
DOPAMINE 4 RECEPTOR ANTIBODY;
DOPAMINE 5 RECEPTOR ANTIBODY;
EPITOPE;
RECEPTOR ANTIBODY;
UNCLASSIFIED DRUG;
ANTIBODY SPECIFICITY;
ANTIGEN RECOGNITION;
ARTICLE;
HUMAN;
HUMAN CELL;
PROTEIN EXPRESSION;
VALIDATION PROCESS;
ANTIBODIES;
ANTIBODY SPECIFICITY;
BLOTTING, WESTERN;
CELL LINE;
HUMANS;
RECEPTORS, DOPAMINE;
RECEPTORS, DOPAMINE D1;
RECEPTORS, DOPAMINE D2;
RECEPTORS, DOPAMINE D3;
RECEPTORS, DOPAMINE D4;
RECEPTORS, DOPAMINE D5;
TRANSFECTION;
|
EID: 60849115247
PISSN: 00281298
EISSN: None
Source Type: Journal
DOI: 10.1007/s00210-008-0384-6 Document Type: Article |
Times cited : (40)
|
References (8)
|